What Experts From The Field Of Fentanyl Citrate Injection Formulations UK Want You To Know?

What Experts From The Field Of Fentanyl Citrate Injection Formulations UK Want You To Know?

Understanding Fentanyl Citrate Injection Formulations in the UK: A Clinical Overview

Fentanyl citrate remains one of the most essential tools in modern anaesthesia and acute pain management across the United Kingdom. As a powerful artificial opioid, its role in the National Health Service (NHS) and private surgical sectors is reputable, mostly due to its rapid start of action and cardiovascular stability. This blog post offers an extensive overview of fentanyl citrate injection solutions readily available in the UK, their clinical signs, regulatory landscape, and administration protocols.

What is Fentanyl Citrate?

Fentanyl citrate is a potent phenylpiperidine-derivative opioid agonist. It was first manufactured in 1960 and rapidly ended up being a cornerstone of perioperative care. In terms of strength, fentanyl is approximately 50 to 100 times more powerful than morphine. Its high lipophilicity permits it to cross the blood-brain barrier rapidly, resulting in an almost instant analgesic result when administered intravenously.

In the UK, fentanyl citrate is mainly utilized through the parenteral route (injection) for both sedative and analgesic functions. It works mainly by binding to the mu-opioid receptors in the central anxious system, altering the perception of discomfort and the emotional reaction to it.

Medical Indications in the UK

According to the British National Formulary (BNF), fentanyl citrate injection is shown for several specific clinical situations:

  • Analgesic Action: Used during brief operative treatments and in the recovery space.
  • Analgesic Supplement: Used during the induction and maintenance of inhalation anaesthesia.
  • Neuroleptanalgesia: Often used in combination with a neuroleptic (such as droperidol) to attain a state of quiescence and decreased awareness.
  • Management of Severe Pain: Particularly in the Intensive Care Unit (ICU) for patients on mechanical ventilation.
  • Pre-medication: To supply sedation and analgesia before the induction of basic anaesthesia.

Readily Available Formulations and Strengths in the UK

The UK market uses several solutions of fentanyl citrate, developed to meet the varying needs of surgical and emergency departments. These are normally provided as clear, colourless options for injection or infusion.

Table 1: Common Fentanyl Citrate Formulations in the UK

Strength (Fentanyl base)PresentationTypical PackagingProducer Examples
50 micrograms/ml2 ml AmpouleLoad of 10Hameln, Advanz Pharma
50 micrograms/ml10 ml AmpouleLoad of 5 or 10Hameln, Wockhardt
50 micrograms/ml20 ml Vial/AmpoulePack of 5Hameln, Generic
50 micrograms/ml50 ml VialIndividual/Pack of 1Generic (ICU use)

Note: While 50 mcg/ml is the basic concentration, specialised formulations for epidural or intrathecal use may in some cases be prepared by healthcare facility pharmacies under specific protocols.

Pharmacokinetics and Pharmacodynamics

Understanding how the body processes fentanyl is essential for safe administration.

  1. Beginning of Action: When administered intravenously, the impact begins almost right away, though the optimum analgesic impact might take 3 to 5 minutes.
  2. Period: A single intravenous dosage of 100 micrograms generally lasts for 30 to 60 minutes.
  3. Metabolic process: Fentanyl is primarily metabolised in the liver via the CYP3A4 enzyme system.
  4. Excretion: Approximately 75% of the dosage is excreted in the urine within 24 hours, mostly as metabolites.

Administration Protocols

In the UK, the administration of fentanyl citrate is strictly managed and normally carried out by anaesthetists or trained specialists in regulated environments.

Dose Guidelines

Dosage should be horizontal and individualised based upon the client's age, weight, physical status, underlying pathological condition, usage of other drugs, and the type of surgery.

  • Low Dose (2 mcg/kg): Useful for minor surgeries.
  • Moderate Dose (2-- 20 mcg/kg): Used when surgical treatment is more invasive; needs breathing monitoring.
  • High Dose (20-- 50 mcg/kg): Used throughout "trouble-free" major surgeries (e.g., open-heart surgery) to safeguard the myocardium from the metabolic demands of tension.

Paths of Administration

  • Intravenous (IV) Bolus: Common for induction.
  • Intravenous Infusion: Used for longer procedures or in the ICU.
  • Intramuscular (IM): Less typical, however used for pre-medication in particular scenarios.

Regulative Status and Safety

In the United Kingdom, Fentanyl is categorized under the Misuse of Drugs Act 1971 as a Class A drug. Under the Misuse of Drugs Regulations 2001, it is classified as a Schedule 2 Controlled Drug (CD POM).

Statutory Requirements for UK Hospitals:

  • Safe Custody: Must be saved in a locked controlled drug cupboard.
  • Record Keeping: Every administration must be tape-recorded in a Controlled Drugs Register (CDR).
  • Damage: Surplus or expired fentanyl must be denatured and seen by authorised workers.

Adverse Effects and Adverse Reactions

While highly effective, fentanyl citrate brings a danger of significant adverse effects.

  • Respiratory Depression: The most major adverse effects, which can cause breathing arrest if not monitored.
  • Bradychardia: Often managed with atropine.
  • Muscle Rigidity (Chest Wall Rigidity): High dosages can make ventilation difficult, requiring making use of neuromuscular blocking agents.
  • Queasiness and Vomiting: Common in the postoperative period.
  • Hypotension: Although more stable than morphine, it can still occur, particularly in hypovolaemic clients.

Comparison with Other Opioids

Clinicians typically choose fentanyl over other opioids due to its specific pharmacokinetic profile.

Table 2: Comparison of Parenteral Opioids in UK Practice

FunctionFentanylMorphineRemifentanil
Relative Potency1001100-200
Onset1-- 3 minutes15-- 30 minutes1 minute
Duration of Action30-- 60 minutes3-- 4 hours5-- 10 minutes
Histamine ReleaseNegligibleConsiderableNegligible
Primary UseIntraoperative/ICUPost-operative/ChronicTitratable Infusion

Regularly Asked Questions (FAQ)

1. Is fentanyl citrate injection the like the fentanyl spots?

No. While they include the very same active drug, the injection is for immediate, acute use in surgical or emergency settings. Patches (transdermal delivery) are created for chronic, long-term pain management and launch the medication slowly over 72 hours.

2. Can fentanyl citrate be used for children in the UK?

Yes, it is regularly used in paediatric anaesthesia. However, the dose should be strictly computed based upon the child's weight, and they should be kept an eye on carefully for breathing anxiety.

3. What is the antagonist for fentanyl?

Naloxone is the particular pharmacological antagonist used to reverse the results of fentanyl, including respiratory depression. In UK hospitals, naloxone needs to constantly be readily offered anywhere fentanyl is administered.

4. Why is it utilized over morphine in heart surgical treatment?

Fentanyl is chosen in cardiac surgery due to the fact that it does not trigger the release of histamine, which can result in vasodilation and hypotension. It provides cardiovascular stability even at high doses.

5. What are  Fentanyl Citrate Solubility UK ?

Fentanyl citrate injection ought to be saved below 25 ° C and safeguarded from light. As a Schedule 2 drug, it needs to be kept in a lawfully compliant CD cupboard.

Fentanyl citrate injection formulas are important parts of the UK's medical toolkit for handling perioperative pain and facilitating intricate surgeries. Its high effectiveness and quick onset offer unequaled precision for anaesthetists, offered that rigorous tracking and regulative requirements are preserved. By understanding the numerous concentrations and the stringent procedures surrounding its usage, healthcare experts guarantee that this effective medication remains both safe and reliable for patients throughout the country.


Disclaimer: This short article is for educational functions just and does not make up medical guidance. Health care professionals should always refer to the Summary of Product Characteristics (SmPC) and current BNF standards for the most updated prescribing information.